Chicago, IL (August 15, 2017) Amin Talati Upadhye, LLP announced that partner Ivan Wasserman has been named the Best Lawyers® 2018 Advertising Law “Lawyer of the Year” for Chicago. While this is the first time MORE >see all news >
We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness: food and beverages, nutritional supplements, cosmetics, medical devices and pharmaceuticals.MORE
Drawing heavily on our IP, patent and trademark expertise, we provide our clients with business advice and strategies that enhance product value and head off future litigation.MORE
We are deeply experienced in FDA and FTC disputes, patent and trademark infringement cases, class actions, breach of contract and unfair competition claims. We are renowned in the area of Paragraph IV litigation, where companies challenge brand name patents so that medications can be marketed in generic forms.MORE
We provide counseling both to generic companies seeking to challenge patents and bring drugs to market, and to brand name pharmaceutical companies seeking to strategically patent and protect their brand name products in the long term.MORE
Three of Amin Talati’s partners, Ivan Wasserman, Ashish Talati, and Erin Conway will be featured speakers at this year’s SupplySide West conference, taking place September 25-29, 2017 in Las Vegas, NV. Information on their presentations, including times can be found below: Wasserman: FDA Lawsuits and Class Action Litigation in the Dietary Supplement Industry – Tuesday, 9/26 | […]
In a recent article featured in Natural Products Insider, Gurnani addresses the often daunting task of auditing a contract manufacturer in the food, dietary supplement, and beverage industries, and how a brand and its manufactures can strategize to make the process less burdensome. To read the full article, please click HERE.
10Law360, “A Look Back At The Top AIA-Related Decisions Of 2016” by Matthew Bultman. Bloomberg BNA’s Pharmaceutical Law & Industry Report: Joe Cwik Discusses Changing Landscape of Patent Infringement Litigation Due to New Inter Partes Review Process. To read the full article, please click HERE.